---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-098865"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2022-04-07T23:59:59+00:00"
generated_at: "2026-06-26T08:51:53.056655+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology appoints Johanna Friedl-Naderer as EVP and COO

## Summary
- Appointed Johanna Friedl-Naderer, age 54, as EVP and COO effective April 4, 2022.
- She previously served as EVP and Chief Business Officer, Global since March 2022.
- Prior to Vir, spent 20+ years at Biogen, most recently as President of Europe, Canada & Partner Markets.
- Responsible for business development, finance, product development/regulatory, and corporate affairs.
- Compensation has not yet been determined; will be disclosed in a future amendment.

## SEC filing metadata
- accession: 0001193125-22-098865
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2022-04-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000119312522098865/0001193125-22-098865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000119312522098865/d254319d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-098865
- JSON: https://secwatch.observer/filing/0001193125-22-098865.json
- Plain text: https://secwatch.observer/filing/0001193125-22-098865.txt

## Key facts
- Executive change
  Johanna Friedl-Naderer was appointed as Executive Vice President and Chief Operating Officer at Vir Biotechnology, Inc..
  - Action: appointed
  - Role: Executive Vice President and Chief Operating Officer
  source text: Effective as of April 4, 2022, the Board of Directors (the “Board”) of Vir Biotechnology, Inc. (the “Company”) appointed Johanna Friedl-Naderer, age 54, to serve as Executive Vice President and Chief Operating Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000119312522098865/0001193125-22-098865-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.